Skip to main content
Clinical Trials/NCT03998072
NCT03998072
Unknown
Not Applicable

Does Five Session CAT (Cognitive Analytic Therapy) Consultancy Lead to Improve Outcomes for Patients and Care Coordinators?

Amrit Sinha1 site in 1 country24 target enrollmentSeptember 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psychological Intervention
Sponsor
Amrit Sinha
Enrollment
24
Locations
1
Primary Endpoint
Personality Structure Questionnaire (PSQ)
Last Updated
6 years ago

Overview

Brief Summary

Five session CAT (Cognitive Analytic Therapy) consultancy was developed for patients whom services 'struggle to help', such as those with diagnoses of personality disorder. Five session CAT consultancy works with both patients and care coordinators, utilising key elements of CAT including reciprocal roles and reformulation to inform care planning and case management. The proposed study expands on the existing evidence base by utilising a comparator; a treatment as usual condition. The proposed mixed methods feasibility study will compare outcomes for both patients and care coordinators to assess the effectiveness of the intervention compared to controls in a community mental health team.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
September 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Amrit Sinha
Responsible Party
Sponsor Investigator
Principal Investigator

Amrit Sinha

Research Support Officer

University of Sheffield

Eligibility Criteria

Inclusion Criteria

  • they are indicated as unsuitable for individual therapy,
  • there is a poor or challenging relationship between the patient and the care coordinator(s)
  • the care coordinator(s) feels a sense of 'stuckness' with the case
  • the patient is chaotic

Exclusion Criteria

  • actively psychotic
  • severely misusing substances
  • have poor appointment attendance
  • indicating that they are actively suicidal and unwilling to commit to trying to stay safe.

Outcomes

Primary Outcomes

Personality Structure Questionnaire (PSQ)

Time Frame: Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks)

Primary outcome measure for patients utilised to measure change across multiple time-points. The PSQ is an 8-item measure of identity disturbance. Each item is rated using a 5-point Likert scale. The maximum score on the scale is 40, indicating a high level of identity disturbance.

Perceived competence scale

Time Frame: Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks)

Primary outcome measure for care coordinators utilised to measure change across multiple time-points. The Perceived Competence Scale is a four item Likert-scale ranging from 1 to 7. The maximum score for each item is 7, and the maximum overall score for the scale is 28, indicating the highest levels of perceived competence.

Secondary Outcomes

  • Clinical Outcomes in Routine Evaluation (CORE-10)(Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks))
  • Working Alliance Inventory Short-Revised (WAI-SR)(Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks))
  • Doubt Subscale of the Mental Health Professionals Stress Scale (MHPSS)(Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks))

Study Sites (1)

Loading locations...

Similar Trials